Turning Point Therapeutics, Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/287cdfd3-95de-4da9-993c-2ca1ff31523a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-238.0M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002302 |
| FY 2020 | $-161.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009849 |
| FY 2019 | $-77.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011492 |
| FY 2018 | $-25.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-011492 |
| FY 2017 | $-16.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-20-011492 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).